Status:
COMPLETED
COVID-19 Health Professional Impact Study
Lead Sponsor:
The Royal Wolverhampton Hospitals NHS Trust
Collaborating Sponsors:
University of Wolverhampton
Conditions:
Coronavirus Infection
Severe Acute Respiratory Syndrome
Eligibility:
All Genders
Phase:
NA
Brief Summary
The COVID-19 (coronavirus) pandemic has had a huge impact on healthcare resources and staff in the UK. Understanding the key risk factors associated with infection amongst healthcare workers is essent...
Detailed Description
Participants will have access to the study via the link given in an SMS (Short Message Service - text message) which will direct then to the first online survey. They will then be contacted again in ...
Eligibility Criteria
Inclusion
- All Staff employed by Royal Wolverhampton Trust, having undergone the SARS-CoV-2antibody test at the Trust's testing facility
Exclusion
- Royal Wolverhampton NHS Trust staff who have not participated in antibody testing • Staff who have opted out to receiving the text message invite and be part of the study
Key Trial Info
Start Date :
November 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2023
Estimated Enrollment :
1504 Patients enrolled
Trial Details
Trial ID
NCT04527432
Start Date
November 24 2020
End Date
October 27 2023
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Wolverhampton NHS Trust
Wolverhampton, United Kingdom, WV10 0QP